Genetic alterations in prostate cancer as diagnostic and prognostic markers

被引：0

作者：

Saeidi, Hamidreza ^{[1
]}

Ismail, Patimah ^{[1
]}

Samudi Raju, Chandramathi ^{[2
]}

Khairul-Asri, Mohd Ghani ^{[3
]}

Bakrin, Ikmal Hisyam ^{[4
]}

机构：

[1] Univ Putra Malaysia, Dept Biomed Sci, Fac Med & Hlth Sci, Serdang, Malaysia

[2] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia

[3] Univ Putra Malaysia, Dept Urol, Fac Med & Hlth Sci, Seri Kembangan, Selangor, Malaysia

[4] Putra Malaysia Univ, Dept Pathol, Fac Med & Hlth Sci, Serdang, Malaysia

来源：

MALAYSIAN JOURNAL OF PATHOLOGY | 2023年 / 45卷 / 02期

关键词：

Prostate cancer; genetic alterations; diagnostic markers; prognostic markers; EARLY PSA RECURRENCE; GERMLINE MUTATIONS; SPOP MUTATIONS; PTEN LOSS; MEN; ABIRATERONE; OUTCOMES; FUSION; TP53; RISK;

D O I：

暂无

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Prostate cancer is the second-most frequently diagnosed cancer in men worldwide. Serum prostate-specific antigen is currently used for the early detection of prostate cancer. However, new biomarkers are needed to decrease over diagnosis and over treatment of prostate cancer due to limitations of prostate-specific antigen. Recently, molecular biomarkers have shown promising results for diagnosis and prognosis of prostate cancer. Molecular biomarkers have improved the sensitivity and specificity of prostate-specific antigen and studies are ongoing to identify molecular biomarkers as a replacement for prostate-specific antigen. This review aims to give an overview of emerging molecular biomarkers for diagnosis and prognosis of prostate cancer.

引用

页码：149 / 155

页数：7

共 50 条

[21] Diagnostic and prognostic biomarkers in prostate cancer
Mehilli, B.
Anila, R.
Topi, F.
Cabiri, Z.
CLINICA CHIMICA ACTA, 2024, 558 : 22 - 22
[22] GENETIC ALTERATIONS IN PROSTATE-CANCER
OCONNOR, MM
WELLS, SA
CATALONA, WJ
DONISKELLER, H
AMERICAN JOURNAL OF HUMAN GENETICS, 1993, 53 (03) : 338 - 338
[23] Commentary: Genetic alterations in prostate cancer
Bochner, BH
JOURNAL OF UROLOGY, 1999, 162 (04): : 1543 - 1543
[24] Race and Genetic Alterations in Prostate Cancer
Schumacher, Fredrick R.
Basourakos, Spyridon P.
Lewicki, Patrick J.
Vince, Randy
Spratt, Daniel E.
Barbieri, Christopher E.
Shoag, Jonathan E.
JCO PRECISION ONCOLOGY, 2021, 5 : 1650 - 1653
[25] GENETIC ALTERATIONS IN PROSTATE-CANCER
ISAACS, WB
BOVA, GS
MORTON, RA
BUSSEMAKERS, MJG
BROOKS, JD
EWING, CM
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1994, 59 : 653 - 659
[26] The reporting of prostate cancer on needle biopsy: prognostic and therapeutic implications and the utility of diagnostic markers
Zhou, M
Epstein, JI
PATHOLOGY, 2003, 35 (06) : 472 - 479
[27] The application of genomic and proteomic approaches to human prostate cancer in developing diagnostic and prognostic markers
Brooks, JD
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2006, 24 (03) : 222 - 223
[28] P-Mark: A European quest for new diagnostic and prognostic markers for prostate cancer
Schenk-Braat, Ellen
Bangma, Chris H.
TUMOR BIOLOGY, 2007, 28 : 51 - 52
[29] Deposition of collagen III and alterations in basement membrane integrity as candidate prognostic markers in prostate cancer
Pinheiro, Lais Capelasso Lucas
Pupim, Andreia Carla Eugenio
Pereira, Erica Romao
Ahrens, Tainah Mendes
Mendonca, Ana Carla
Francelino, Amanda Leticia
Araujo, Eduardo Jose de Almeida
Guembarovski, Alda Fiorina Maria Losi
Fuganti, Paulo Emilio
Vanzela, Andre Luis Laforga
Colus, Ilce Mara de Syllos
Favaron, Phelipe Oliveira
Miqueloto, Carlos Alberto
Guembarovski, Roberta Losi
EXPERIMENTAL CELL RESEARCH, 2024, 439 (01)
[30] Genetic prognostic markers for colorectal cancer
Offit, K
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (02): : 124 - 125

← 1 2 3 4 5 →